Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - gadodiamide, quantity: 287 mg/ml - injection, solution - excipient ingredients: water for injections; caldiamide sodium hydrate; hydrochloric acid; sodium hydroxide - other conditions: do not freeze. omniscan is indicated for use in adults and children from 6 months of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood brain barrier or abnormal vascularity. indications as at 10 december 1999: omniscan is indicated for use in adults and children from 6 months of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity and whole body imaging. indications as at 25 june 2003: omniscan is indicated for: 1) use in adults and children, including infants and neonates less than 6 months of age for the enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity, and; 2) whole body imaging for adults and children over 6 months of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 755.3 mg/ml (equivalent: iodine, qty 370 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; hydrochloric acid; trometamol - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 755.3 mg/ml (equivalent: iodine, qty 370 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; trometamol; water for injections; sodium calcium edetate - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 755.3 mg/ml (equivalent: iodine, qty 370 mg/ml) - injection, solution - excipient ingredients: water for injections; trometamol; hydrochloric acid; sodium calcium edetate - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 612.4 mg/ml (equivalent: iodine, qty 300 mg/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium calcium edetate; trometamol - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 612.4 mg/ml (equivalent: iodine, qty 300 mg/ml) - injection, solution - excipient ingredients: water for injections; trometamol; sodium calcium edetate; hydrochloric acid - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - gadodiamide, quantity: 287 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; purified water; hydrochloric acid; caldiamide sodium hydrate - other conditions: do not freeze. omniscan is indicated for use in adults and children from 6 months of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood brain barrier or abnormal vascularity. indications as at 10 december 1999: omniscan is indicated for use in adults and children from 6 months of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularlity and whole body imaging. indications as at 25 june 2003: omniscan is indicated for: 1) use in adults and children, including infants and neonates less than 6 months of age for the enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity, and; 2) whole body imaging for adults and children over 6 months of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - solution - excipient ingredients: meglumine; water for injections; tetraxetan - clariscan is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - solution - excipient ingredients: meglumine; water for injections; tetraxetan - clariscan is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - solution - excipient ingredients: meglumine; water for injections; tetraxetan - clariscan is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).